Today, President von der Leyen held a videoconference with the CEOs of the pharmaceutical companies with which the European Commission has signed Advance Purchase Agreements, in the context of our Vaccines Strategy – BionNTech/Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Curevac and Sanofi. Commissioners Stella Kyriakides and Thierry Breton, the President‘s coronavirus special advisor Peter Piot and Moncef Slaoui, as well as the Executive Director of the European Medicines Agency, Emer Cook, also attended. The aim of the videoconference was to launch the work on European bio-defence preparedness. The Commission will set up an EU Health Emergency Preparedness and Response Authority (HERA), to deliver a more structured approach to pandemic preparedness. HERA will help anticipate threats and identify responses.
Continue reading…
Gone are the days when organisations could simply promise a speak up culture. Today, fostering a culture of trust, integrity, and a positive work environment…
Download whitepaper